Start for free

Strides Pharma Science Limited

NSE: STARHealthcare

Strides Pharma Science Limited Share Price & Analysis

₹1059.60+0.57%Updated 4 Sept 2026, 03:30 pm IST
LTP
₹1059.60+0.57%
Open
₹1040.80
High
₹1066.50
Low
₹1040.70
Close
₹1059.60
52W High
₹1231.00
52W Low
₹768.65
Volume
217K
Lot Size
1
Sector
Healthcare
Market Cap
₹10K Cr
Face Value
₹10
Mid Cap

Price Chart

Candle
Range

Fundamentals

P/E
16.90
Sector P/E
54.70
P/B
3.59
EPS
₹60.39
ROE
20.00%
ROCE
18.30%
D/E Ratio
0.56
Div Yield
0.47%
Book Value
₹337.00

Strengths

  • Excellent return on equity (ROE 20%)
  • Efficient capital deployment (ROCE 18.3%)
  • Attractively valued vs sector (P/E 16.9x vs industry 54.7x)

Concerns

    Peer Comparison

    CompanyCMPMkt CapP/EP/BROE %ROCE %D/E
    SUNPHARMA
    Sun Pharmaceutical Industries Limited
    ₹1,899
    		₹4.6L Cr36.15.461620.50.07
    DIVISLAB
    Divi's Laboratories Limited
    ₹9,100
    		₹2.4L Cr81.114.4216.5220.01
    TORNTPHARM
    Torrent Pharmaceuticals Limited
    ₹4,857
    		₹1.8L Cr82.819.5827.415.20.33
    APOLLOHOSP
    Apollo Hospitals Enterprise Limited
    ₹8,650
    		₹1.2L Cr59.113.1321.217.40.88
    CIPLA
    Cipla Limited
    ₹1,385
    		₹1.1L Cr31.33.2511.615.50.01
    ZYDUSLIFE
    Zydus Lifesciences Limited
    ₹1,120
    		₹1.1L Cr234.1621.221.10.38
    LAURUSLABS
    Laurus Labs Limited
    ₹1,840
    		₹99K Cr90.918.7418.317.80.46

    Showing 7 peers in the same sector · Sorted by market cap

    Shareholding Pattern

    STAR · as of Mar 2026

    Promoters28.30%1.48pp
    FII28.32%0.16pp
    DII13.72%3.20pp
    Public29.65%1.87pp
    Govt0.01%
    CategoryDec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
    Promoters27.39%25.88%25.86%25.84%26.82%28.30%
    FII19.45%24.57%26.71%30.08%28.48%28.32%
    DII19.02%17.66%18.17%18.24%16.92%13.72%
    Public33.75%31.52%28.87%25.83%27.78%29.65%
    Govt0.39%0.39%0.39%0.01%0.01%0.01%

    Corporate Events

    Dividend - Rs 5 Per Share

    Dividend30 Jul 2026

    To consider and approve the unaudited financial results (standalone and consolidated) of the Company for the quarter ended Jun 30, 2026

    Results30 Jul 2026

    Dividend - Rs 4 Per Share

    Dividend21 Jul 2025

    Demerger

    Event5 Dec 2024

    Dividend - Rs 2.50 Per Share

    Dividend8 Sept 2024

    Dividend - Rs 1.50 Per Share

    Dividend3 Aug 2023

    Latest News

    All news

    Strides Pharma reports Q1FY27 revenue of ₹12,654m, up 13% YoY

    *Strides Pharma reports Q1FY27 revenue of ₹12,654m, up 13% YoY*. **Revenue reached ₹12,654 million**, growing **13% YoY**, driven by strong performance in international markets. Ex-US markets surged **17% YoY**, indicating robust global demand. The company delivered a steady operational performance despite ongoing regulatory challenges in key geographies. 📊 *STOCKS:* $STRAIPPHARMA | 🏢 *SECTOR:* Pharma | #HIGHIMPACT #Earnings

    NSE Filing31 Jul
    High Impact

    Strides Pharma reports Q1 FY27 financial results

    *Strides Pharma reports Q1 FY27 financial results.* The company has announced its financial performance for the quarter ended June 30, 2026. Results include key metrics such as revenue, profit after tax, and operating margins. Traders to assess performance versus estimates and guidance. 📊 *STOCKS:* $SCI | 🏢 *SECTOR:* Pharma | #HIGHIMPACT #Earnings

    NSE Filing31 Jul
    High Impact

    Star Health hosts analyst call after Q1 results

    *Star Health hosts analyst call after Q1 results*. The company shared updates during its investor meet on July 30, 2026, with an audio recording made available. Discussion likely centered on **Q1 performance**, claims ratio, and premium growth. No new financial revisions were announced. 📊 *STOCKS:* $STAR | 🏢 *SECTOR:* Insurance | #MEDIUMIMPACT #Earnings

    NSE Filing30 Jul
    Medium Impact

    Strides Pharma reports Q1 FY27 updates

    *Strides Pharma reports Q1 FY27 updates* as per a recent NSE filing. The company shared general corporate updates with no major financial figures or strategic shifts disclosed. Investors await further details on performance or guidance. 📊 *STOCKS:* $STRAIPHA | 🏢 *SECTOR:* Pharma | #LOWIMPACT #Pharma

    NSE Filing31 Jul
    Low Impact

    Disney injects ₹123 crore into JioStar India

    *Disney injects ₹123 crore into JioStar India* to strengthen its post-merger operations. This follows the recent integration of Disney’s Indian media assets with Reliance’s JioStar. The move signals continued confidence in the combined entity’s growth strategy. JioStar operates under Reliance Industries, which owns the controlling stake. 📊 *STOCKS:* RELIANCE | 🏢 *SECTOR:* Corporate | #MEDIUMIMPACT #JioStar

    Storyboard182 Jul
    Medium Impact

    Disney invests ₹123 Cr in JioStar India joint venture

    Disney has infused ₹**123 Cr** into its Indian joint venture, JioStar, boosting its media and entertainment footprint. The move strengthens the partnership between Disney and Reliance Industries in India’s competitive OTT and TV segment. The capital injection reflects continued confidence in India’s media growth story. 📊 *STOCKS:* | 🏢 *SECTOR:* Corporate | #MEDIUMIMPACT #JointVenture

    outlookbusiness.com1 Jul
    Medium Impact

    JioStar eases pressure on Disney with improved India performance

    *JioStar eases pressure on Disney with improved India performance.* The integration of JioCinema and Star India is showing positive traction, reducing losses in Disney’s Indian operations. Revenue from Indian streaming now contributes **$200 million annually**, with subscriber growth up **15% YoY**. This turnaround lessens the drag on Disney’s global earnings. 📊 *STOCKS:* TWDC | 🏢 *SECTOR:* Corporate | #MEDIUMIMPACT #Disney

    PitchOnnet25 May
    Medium Impact

    Financials

    Quarterly Results

    MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
    Revenue
    ₹1.3K Cr
    10.7%
    ₹1.2K Cr
    2.1%
    ₹1.2K Cr
    9.0%
    ₹1.1K Cr
    5.9%
    ₹1.2K Cr
    3.1%
    ₹1.2K Cr
    1.1%
    ₹1.2K Cr
    10.7%
    ₹1.1K Cr
    Op. Profit
    ₹240 Cr
    1.7%
    ₹236 Cr
    2.2%
    ₹231 Cr
    6.0%
    ₹218 Cr
    0.0%
    ₹218 Cr
    3.8%
    ₹210 Cr
    14.1%
    ₹184 Cr
    2.1%
    ₹188 Cr
    OPM
    18.0%
    10.0%
    20.0%
    5.3%
    19.0%
    0.0%
    19.0%
    5.6%
    18.0%
    0.0%
    18.0%
    12.5%
    16.0%
    11.1%
    18.0%
    Net Profit
    ₹129 Cr
    38.0%
    ₹208 Cr
    57.6%
    ₹132 Cr
    24.5%
    ₹106 Cr
    23.3%
    ₹86 Cr
    4.4%
    ₹90 Cr
    25.0%
    ₹72 Cr
    97.9%
    ₹3.4K Cr
    EPS (₹)
    13.77
    37.2%
    21.93
    58.5%
    13.84
    28.1%
    10.8
    21.2%
    8.91
    6.6%
    9.54
    22.2%
    7.81
    97.9%
    364.69

    Values in ₹ Cr · Source: Screener.in

    Annual Profit & Loss

    MetricMar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017
    Revenue
    ₹4.9K Cr
    6.4%
    ₹4.6K Cr
    17.4%
    ₹3.9K Cr
    5.5%
    ₹3.7K Cr
    20.1%
    ₹3.1K Cr
    7.4%
    ₹3.3K Cr
    20.5%
    ₹2.8K Cr
    26.4%
    ₹2.2K Cr
    23.4%
    ₹2.8K Cr
    3.3%
    ₹2.8K Cr
    Expenses
    ₹3.9K Cr
    4.5%
    ₹3.8K Cr
    11.9%
    ₹3.4K Cr
    5.1%
    ₹3.5K Cr
    10.7%
    ₹3.2K Cr
    15.2%
    ₹2.8K Cr
    18.9%
    ₹2.3K Cr
    18.0%
    ₹2.0K Cr
    19.0%
    ₹2.4K Cr
    9.9%
    ₹2.2K Cr
    Op. Profit
    ₹925 Cr
    15.2%
    ₹803 Cr
    52.1%
    ₹528 Cr
    264.1%
    ₹145 Cr
    210.7%
    ₹-131 Cr
    124.4%
    ₹537 Cr
    29.7%
    ₹414 Cr
    110.2%
    ₹197 Cr
    50.5%
    ₹398 Cr
    24.5%
    ₹527 Cr
    OPM
    19.0%
    5.6%
    18.0%
    28.6%
    14.0%
    259.0%
    3.9%
    190.7%
    -4.3%
    126.9%
    16.0%
    6.7%
    15.0%
    66.7%
    9.0%
    35.7%
    14.0%
    26.3%
    19.0%
    Other Income
    ₹124 Cr
    96.3%
    ₹3.3K Cr
    3413.0%
    ₹-100 Cr
    208.7%
    ₹92 Cr
    182.1%
    ₹-112 Cr
    202.8%
    ₹109 Cr
    353.5%
    ₹-43 Cr
    114.2%
    ₹303 Cr
    52.9%
    ₹643 Cr
    121.0%
    ₹291 Cr
    Interest
    ₹179 Cr
    28.1%
    ₹249 Cr
    11.1%
    ₹280 Cr
    7.3%
    ₹261 Cr
    47.5%
    ₹177 Cr
    18.0%
    ₹150 Cr
    3.8%
    ₹156 Cr
    97.5%
    ₹79 Cr
    59.7%
    ₹196 Cr
    7.1%
    ₹183 Cr
    Depreciation
    ₹202 Cr
    5.2%
    ₹192 Cr
    10.3%
    ₹214 Cr
    11.9%
    ₹243 Cr
    4.3%
    ₹233 Cr
    13.1%
    ₹206 Cr
    18.4%
    ₹174 Cr
    48.7%
    ₹117 Cr
    24.0%
    ₹154 Cr
    22.2%
    ₹126 Cr
    PBT
    ₹669 Cr
    81.8%
    ₹3.7K Cr
    5753.8%
    ₹-65 Cr
    75.7%
    ₹-268 Cr
    59.0%
    ₹-653 Cr
    326.0%
    ₹289 Cr
    588.1%
    ₹42 Cr
    86.1%
    ₹303 Cr
    56.1%
    ₹690 Cr
    35.6%
    ₹509 Cr
    Tax %
    14.0%
    600.0%
    2.0%
    95.6%
    45.0%
    314.3%
    -21.0%
    22.2%
    -27.0%
    345.5%
    11.0%
    59.3%
    27.0%
    400.0%
    -9.0%
    1000.0%
    1.0%
    91.7%
    12.0%
    Net Profit
    ₹575 Cr
    84.0%
    ₹3.6K Cr
    3927.7%
    ₹-94 Cr
    55.7%
    ₹-212 Cr
    55.3%
    ₹-474 Cr
    283.7%
    ₹258 Cr
    732.3%
    ₹31 Cr
    90.6%
    ₹330 Cr
    51.8%
    ₹684 Cr
    53.4%
    ₹446 Cr
    EPS (₹)
    60.34
    84.5%
    389.75
    5174.9%
    -7.68
    65.8%
    -22.44
    56.2%
    -51.25
    271.2%
    29.93
    637.2%
    4.06
    88.8%
    36.27
    51.2%
    74.25
    66.1%
    44.71
    Div Payout
    8.0%
    700.0%
    1.0%
    103.0%
    -33.0%
    371.4%
    -7.0%
    0.0%
    100.0%
    8.0%
    97.7%
    345.0%
    4212.5%
    8.0%
    166.7%
    3.0%
    70.0%
    10.0%

    Values in ₹ Cr · Source: Screener.in

    Balance Sheet

    ItemMar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017
    Liabilities
    Equity Capital
    ₹92 Cr
    0.0%
    ₹92 Cr
    0.0%
    ₹92 Cr
    2.2%
    ₹90 Cr
    0.0%
    ₹90 Cr
    0.0%
    ₹90 Cr
    0.0%
    ₹90 Cr
    0.0%
    ₹90 Cr
    0.0%
    ₹90 Cr
    1.1%
    ₹89 Cr
    Reserves
    ₹3.0K Cr
    22.6%
    ₹2.5K Cr
    20.9%
    ₹2.0K Cr
    4.1%
    ₹2.1K Cr
    6.5%
    ₹2.3K Cr
    15.6%
    ₹2.7K Cr
    10.2%
    ₹2.4K Cr
    4.7%
    ₹2.6K Cr
    7.8%
    ₹2.4K Cr
    10.7%
    ₹2.7K Cr
    Borrowings
    ₹1.8K Cr
    6.5%
    ₹1.9K Cr
    25.3%
    ₹2.5K Cr
    16.9%
    ₹3.0K Cr
    0.2%
    ₹3.0K Cr
    28.8%
    ₹2.3K Cr
    5.1%
    ₹2.2K Cr
    30.6%
    ₹3.2K Cr
    27.8%
    ₹2.5K Cr
    31.9%
    ₹3.7K Cr
    Other Liabilities
    ₹1.9K Cr
    29.6%
    ₹1.5K Cr
    29.5%
    ₹1.2K Cr
    14.4%
    ₹1.4K Cr
    13.1%
    ₹1.6K Cr
    15.6%
    ₹1.8K Cr
    34.7%
    ₹1.4K Cr
    29.3%
    ₹1.9K Cr
    21.0%
    ₹1.6K Cr
    0.2%
    ₹1.6K Cr
    Total Liabilities
    ₹6.8K Cr
    14.8%
    ₹5.9K Cr
    2.2%
    ₹5.8K Cr
    12.1%
    ₹6.6K Cr
    5.0%
    ₹6.9K Cr
    0.4%
    ₹7.0K Cr
    13.7%
    ₹6.1K Cr
    21.5%
    ₹7.8K Cr
    18.6%
    ₹6.6K Cr
    18.2%
    ₹8.0K Cr
    Assets
    Fixed Assets
    ₹2.1K Cr
    10.6%
    ₹1.9K Cr
    1.8%
    ₹1.9K Cr
    19.3%
    ₹2.3K Cr
    1.5%
    ₹2.3K Cr
    5.8%
    ₹2.2K Cr
    5.7%
    ₹2.1K Cr
    42.5%
    ₹3.6K Cr
    22.5%
    ₹3.0K Cr
    0.1%
    ₹3.0K Cr
    CWIP
    ₹447 Cr
    115.9%
    ₹207 Cr
    27.8%
    ₹162 Cr
    7.3%
    ₹151 Cr
    48.1%
    ₹291 Cr
    34.9%
    ₹447 Cr
    8.2%
    ₹413 Cr
    8.8%
    ₹453 Cr
    26.9%
    ₹620 Cr
    20.5%
    ₹780 Cr
    Investments
    ₹291 Cr
    28.9%
    ₹409 Cr
    35.0%
    ₹303 Cr
    38.2%
    ₹490 Cr
    9.3%
    ₹540 Cr
    22.5%
    ₹697 Cr
    27.0%
    ₹549 Cr
    21.8%
    ₹702 Cr
    19.4%
    ₹588 Cr
    61.4%
    ₹1.5K Cr
    Other Assets
    ₹4.0K Cr
    16.2%
    ₹3.4K Cr
    1.6%
    ₹3.5K Cr
    4.7%
    ₹3.6K Cr
    3.2%
    ₹3.8K Cr
    4.4%
    ₹3.6K Cr
    17.4%
    ₹3.1K Cr
    2.2%
    ₹3.0K Cr
    25.2%
    ₹2.4K Cr
    13.1%
    ₹2.8K Cr
    Total Assets
    ₹6.8K Cr
    14.8%
    ₹5.9K Cr
    2.2%
    ₹5.8K Cr
    12.1%
    ₹6.6K Cr
    5.0%
    ₹6.9K Cr
    0.4%
    ₹7.0K Cr
    13.7%
    ₹6.1K Cr
    21.5%
    ₹7.8K Cr
    18.6%
    ₹6.6K Cr
    18.2%
    ₹8.0K Cr

    Values in ₹ Cr · Source: Screener.in

    Cash Flow Statement

    ItemMar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017
    Operating CF
    ₹703 Cr
    2.8%
    ₹684 Cr
    2.4%
    ₹701 Cr
    1493.2%
    ₹44 Cr
    117.1%
    ₹-258 Cr
    153.6%
    ₹481 Cr
    134.6%
    ₹205 Cr
    241.7%
    ₹60 Cr
    67.9%
    ₹187 Cr
    35.1%
    ₹288 Cr
    Investing CF
    ₹-173 Cr
    92.2%
    ₹-90 Cr
    40.0%
    ₹-150 Cr
    149.7%
    ₹302 Cr
    353.8%
    ₹-119 Cr
    77.2%
    ₹-522 Cr
    139.5%
    ₹1.3K Cr
    1011.0%
    ₹-145 Cr
    125.4%
    ₹570 Cr
    146.6%
    ₹-1.2K Cr
    Financing CF
    ₹-453 Cr
    29.5%
    ₹-643 Cr
    7.2%
    ₹-693 Cr
    223.8%
    ₹-214 Cr
    150.8%
    ₹421 Cr
    2731.3%
    ₹-16 Cr
    99.1%
    ₹-1.7K Cr
    980.9%
    ₹194 Cr
    119.1%
    ₹-1.0K Cr
    400.6%
    ₹338 Cr
    Net Cash Flow
    ₹76 Cr
    258.3%
    ₹-48 Cr
    66.2%
    ₹-142 Cr
    206.8%
    ₹133 Cr
    195.6%
    ₹45 Cr
    180.4%
    ₹-56 Cr
    69.6%
    ₹-184 Cr
    267.3%
    ₹110 Cr
    142.5%
    ₹-259 Cr
    56.5%
    ₹-596 Cr
    Free Cash Flow
    ₹291 Cr
    42.4%
    ₹505 Cr
    24.9%
    ₹672 Cr
    1662.8%
    ₹-43 Cr
    86.8%
    ₹-326 Cr
    273.4%
    ₹188 Cr
    224.1%
    ₹58 Cr
    122.7%
    ₹-256 Cr
    20.8%
    ₹-212 Cr
    45.1%
    ₹-386 Cr

    Values in ₹ Cr · Source: Screener.in

    Key Ratios History

    MetricMar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017
    Debtor Days
    97d
    1.0%
    96d
    10.3%
    107d
    17.1%
    129d
    10.4%
    144d
    18.0%
    122d
    1.6%
    124d
    24.8%
    165d
    46.0%
    113d
    14.4%
    132d
    Inventory Days
    305d
    29.2%
    236d
    0.4%
    235d
    8.6%
    257d
    9.8%
    285d
    13.4%
    329d
    29.5%
    254d
    13.6%
    294d
    101.4%
    146d
    30.1%
    209d
    Days Payable
    244d
    28.4%
    190d
    6.7%
    178d
    19.1%
    220d
    15.4%
    260d
    19.5%
    323d
    24.7%
    259d
    13.4%
    299d
    59.0%
    188d
    14.9%
    221d
    Cash Conv. Cycle
    157d
    11.3%
    141d
    14.0%
    164d
    0.6%
    165d
    1.8%
    168d
    31.3%
    128d
    7.6%
    119d
    25.6%
    160d
    125.4%
    71d
    40.8%
    120d
    Working Capital Days
    38d
    58.3%
    24d
    226.3%
    -19d
    72.7%
    -11d
    60.7%
    -28d
    27.3%
    -22d
    68.6%
    -70d
    0.0%
    -70d
    1650.0%
    -4d
    96.7%
    -122d
    ROCE
    18.0%
    20.0%
    15.0%
    114.3%
    7.0%
    0.0%
    100.0%
    -5.0%
    162.5%
    8.0%
    60.0%
    5.0%
    150.0%
    2.0%
    87.5%
    16.0%
    45.5%
    11.0%

    Source: Screener.in · Lower days = better efficiency

    Related Analysis

    Same Sector

    ALKEMAlkem Laboratories LimitedNeutralAPOLLOHOSPApollo Hospitals Enterprise LimitedNeutralAUROPHARMAAurobindo Pharma LimitedNeutralBIOCONBiocon LimitedNeutralCIPLACipla LimitedNeutral

    Frequently Asked Questions

    What is Strides Pharma Science Limited share price today?
    Strides Pharma Science Limited (STAR) is currently trading at ₹1,059.6 on NSE, up 0.57% as of the last market session. Prices update daily after market close on MarketNetra.
    Is Strides Pharma Science Limited available in F&O (Futures & Options)?
    Yes, Strides Pharma Science Limited (STAR) is part of the NSE F&O segment with a lot size of 1 shares. Options are available with monthly expiry contracts. You can track the full option chain and OI analysis on MarketNetra.
    What is Strides Pharma Science Limited 52-week high and low?
    Strides Pharma Science Limited's 52-week high is ₹1,231 and the 52-week low is ₹768.65. The current price of ₹1,059.6 is 13.9% below the 52W high.
    What is Strides Pharma Science Limited P/E ratio?
    Strides Pharma Science Limited's current P/E ratio is 16.9. This indicates the market is paying ₹16.9 for every ₹1 of earnings. Compare this to the sector average to assess relative valuation.
    How to trade Strides Pharma Science Limited options?
    Strides Pharma Science Limited options are traded on NSE with monthly expiry contracts (lot size: 1 shares). To trade STAR options: select your expiry on the option chain page, identify key OI strikes, check the PCR and buildup type on OI analysis, and review FII/DII flows for institutional sentiment before taking a position.